Skip to main content

Table 5 Safety assessments in participants taking either rice bran fermented with Lentinus edodes (RBEP) or placebo 1

From: Dietary supplementation with rice bran fermented with Lentinus edodesincreases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study

 

RBEP (n = 40)

Placebo (n = 37)

Week 0

Week 4

Week 8

Week 0

Week 4

Week 8

Red blood cell count (× 1012/L)

4.33 ± 0.43

4.47 ± 0.50

4.47 ± 0.44

4.38 ± 0.43

4.58 ± 0.41

4.56 ± 0.42

White blood cell count (× 109/L)

5.96 ± 1.14

5.82 ± 1.21

5.52 ± 1.12

5.85 ± 1.40

5.79 ± 1.16

5.85 ± 1.20

Hemoglobin (g/L)

140.10 ± 13.10

138.70 ± 14.00

139.60 ± 13.30

140.10 ± 12.60

140.50 ± 12.00

140.30 ± 12.70

Hematocrit (%)

41.45 ± 4.13

42.38 ± 4.48

42.09 ± 3.85

41.46 ± 3.90

42.76 ± 3.62

42.34 ± 3.99

Platelet count (× 109/L)

236.13 ± 39.602

242.18 ± 46.44

243.35 ± 45.91

259.11 ± 61.152

266.19 ± 55.50

267.97 ± 46.08

Segmented neutrophils (%)

54.75 ± 7.61

53.25 ± 5.79

53.30 ± 7.13

54.65 ± 8.47

54.91 ± 5.77

54.97 ± 5.95

Lymphocytes (%)

34.83 ± 7.29

37.60 ± 5.95

36.80 ± 6.65

36.27 ± 7.25

35.78 ± 5.80

35.05 ± 5.52

Monocytes (%)

6.63 ± 1.51

5.90 ± 1.22

6.53 ± 1.45

6.19 ± 1.29

5.84 ± 1.48

6.30 ± 1.61

Eosinophils (%)

2.78 ± 1.21

2.38 ± 0.90

2.38 ± 1.17

2.51 ± 1.26

2.32 ± 1.08

2.73 ± 1.35

Basophils (%)

1.03 ± 0.48

0.88 ± 0.52

1.00 ± 0.55

0.84 ± 0.55

0.97 ± 0.44

0.95 ± 0.57

AST (U/I)

21.25 ± 6.41

21.88 ± 7.77

23.58 ± 9.67

25.24 ± 11.25

24.16 ± 7.30

25.65 ± 10.63

ALT (U/I)

17.20 ± 14.66

17.50 ± 22.40

25.53 ± 27.40

22.51 ± 16.31

21.24 ± 13.41

27.57 ± 19.08

Total protein (g/L)

72.20 ± 4.00

72.60 ± 5.00

73.50 ± 3.90

73.20 ± 3.80

72.50 ± 5.30

74.20 ± 3.70

Glucose (mmol/L)

4.43 ± 0.37

4.31 ± 0.30

4.86 ± 0.45

4.55 ± 0.37

4.44 ± 0.31

4.97 ± 0.38

Total cholesterol (mmol/L)

4.74 ± 0.81

4.64 ± 0.81

5.00 ± 0.84

4.87 ± 0.90

4.81 ± 0.90

5.22 ± 0.88

Blood urea nitrogen (mmol/L)

4.33 ± 0.81

4.51 ± 1.16

4.84 ± 1.12

4.45 ± 1.07

4.59 ± 1.21

5.03 ± 1.10

Creatinine (μmol/L)

60.25 ± 10.68

68.63 ± 15.25

61.01 ± 10.68

61.77 ± 14.49

67.11 ± 14.21

62.53 ± 14.00

Uric acid (μmol/L)

294.43 ± 63.642

281.34 ± 55.91

311.08 ± 73.16

318.81 ± 74.35

293.24 ± 60.07

342.60 ± 77.32

Calcium (mmol/L)

2.24 ± 0.08

2.27 ± 0.06

2.25 ± 0.06

2.23 ± 0.08

2.26 ± 0.07

2.24 ± 0.06

Phosphorus (mmol/L)

1.14 ± 0.14

1.24 ± 0.10

1.22 ± 0.09

1.15 ± 0.12

1.21 ± 0.12

1.22 ± 0.11

SBP (mmHg)

116.43 ± 15.20

116.03 ± 11.76

120.15 ± 13.55

118.87 ± 11.73

117.46 ± 12.05

121.32 ± 13.54

DBP (mmHg)

71.73 ± 9.73

71.98 ± 9.74

74.85 ± 9.73

71.11 ± 8.97

73.65 ± 9.39

75.59 ± 10.39

Pulse rate (beats/min)

76.48 ± 9.93

75.53 ± 10.89

75.50 ± 10.61

73.22 ± 11.01

75.54 ± 10.81

74.68 ± 10.24

Body temperature (°C)

36.24 ± 0.38

35.95 ± 0.35

35.97 ± 0.44

36.29 ± 0.41

36.15 ± 0.44

36.04 ± 0.42

  1. 1Values shown represent means ± standard deviation. AST, Aspartate aminotransferase; AT, Alanine aminotransferase; SBP, Systolic blood pressure; DBP, Diastolic blood pressure.
  2. 2 P-values < 0.05 for differences between the RBEP and placebo groups at week 0 were determined using the independent t-test.